Oncodesign and the Laboratory for Neurobiology and Gene Therapy at the KU Leuven enter into a research collaboration for advancing drug discovery efforts with Ipsen in Parkinson's disease
Oncodesign enters into a research collaboration and license agreement with Sanofi for the application of Oncodesign’s Nanocyclix® technology to Sanofi’s Kinase targets